Seeking Alpha

Perrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval...

Perrigo (PRGO -0.5%) says its partner, Cobrek Pharmaceuticals, has received final FDA approval for its Abbreviated New Drug Application for betamethasone valerate foam, the generic equivalent of Luxiq Foam. Perrigo has manufactured the product and is preparing to begin shipping on January 15, 2013, in line with the launch date.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|